Adult Vaccines are an essential component of preventive healthcare, offering protection against a range of infectious diseases that can pose serious risks to adults' health and well-being. While often overshadowed by childhood vaccination programs, adult immunization is equally crucial for maintaining individual health and preventing the spread of contagious illnesses within communities. Influenza, commonly known as the flu, is a prime example of a vaccine-preventable disease that affects millions of adults worldwide each year. Annual flu vaccination is recommended for all adults, particularly those at higher risk of complications, such as older adults, pregnant women, and individuals with chronic health conditions.
Another important adult vaccine is the tetanus, diphtheria, and pertussis (Tdap) vaccine. Tetanus, a bacterial infection that affects the nervous system, can be transmitted through wounds or cuts and can lead to severe muscle spasms and respiratory failure. The Tdap vaccine provides protection against tetanus, diphtheria, and pertussis (whooping cough) and is recommended for adults who have not received a Tdap vaccine previously. Human papillomavirus (HPV) vaccine is another critical immunization for adults, particularly for those who may not have been vaccinated during adolescence. Vaccination against HPV can help prevent these cancers and is recommended for adults up to age 45.
Despite the clear benefits of adult vaccination, coverage rates remain suboptimal. Barriers to vaccination include lack of awareness, limited access to healthcare services, and vaccine hesitancy. Public health efforts are needed to increase awareness of the importance of adult immunization, improve access to vaccines, and address misconceptions about vaccine safety and efficacy.
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Prophylactic and Molecular Approaches for Mitigating Human Influenza A Viruses: i. Evaluating influenza Vaccine Effectiveness in the Older population ii. Down-regulation of influenza virus genes with novel siRNA-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a Novel Multi-component Vaccine to Address the Burden of Otitis Media in High-Risk Populations
Ayesha Zahid, Griffith University, Australia
Title : Targeting resistance: New 4-substituted pyrazolidine and isoxazolidine as antibiotics with interesting antimicrobial activities
Yousfi Tarek, Nationale Research for Biotechnology Research Center, Algeria
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Immunosuppression in COVID-19 Patients and Emerging Fungal Infections: Vaccines, Diagnosis and Strategies to Treat Comorbidities
K R Aneja, Kurukshetra University, India
Title : Immunogenicity and Cryo-EM structure of native-like HIV-1 Clade-C envelope trimers derived from a pediatric elite-neutralizer
Swarandeep Singh, All India Institute of Medical Sciences, India
Title : Why is the vaccine life-threatening if people get a fever after a COVID-19 vaccination
Yacob Mathai, Marma Health Centre, India
Title : Barriers to polio eradication in South Asia: A systematic review
Awranoos Ahadi, Bolan Medical College, Pakistan